293 related articles for article (PubMed ID: 34536536)
1. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
[TBL] [Abstract][Full Text] [Related]
2. MiR-185-5p suppresses acute myeloid leukemia by inhibiting GPX1.
Pang B; Mao H; Wang J; Yang W
Microvasc Res; 2022 Mar; 140():104296. PubMed ID: 34863990
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
Yuan J; Zhang J; Zhao B; Liu F; Liu T; Duan Y; Chen Y; Chen X; Zou Y; Zhang L; Guo Y; Yang W; Yang Y; Wei J; Zhu X; Zhang Y
Cancer Lett; 2024 Aug; 596():217018. PubMed ID: 38844062
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.
Wang P; Zhang Y; Cai Q; Long Q; Pan S; Zhou W; Deng T; Mo W; Wang S; Zhang Y; Wang C; Chen C
Ann Med; 2023 Dec; 55(1):2201507. PubMed ID: 37070487
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
Tohumeken S; Baur R; Böttcher M; Stoll A; Loschinski R; Panagiotidis K; Braun M; Saul D; Völkl S; Baur AS; Bruns H; Mackensen A; Jitschin R; Mougiakakos D
Cancer Res; 2020 Sep; 80(17):3663-3676. PubMed ID: 32605996
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
7. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
[TBL] [Abstract][Full Text] [Related]
8. Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.
Irandoust M; Alvarez Zarate J; Hubeek I; van Beek EM; Schornagel K; Broekhuizen AJ; Akyuz M; van de Loosdrecht AA; Delwel R; Valk PJ; Sonneveld E; Kearns P; Creutzig U; Reinhardt D; de Bont ES; Coenen EA; van den Heuvel-Eibrink MM; Zwaan CM; Kaspers GJ; Cloos J; van den Berg TK
PLoS One; 2013; 8(1):e52143. PubMed ID: 23320069
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive role of CD11b
Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Ferraro F; Miller CA; Christensen KA; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Kohlschmidt J; Eisfeld AK; Bloomfield CD; Ramakrishnan SM; Day RB; Wartman LD; Uy GL; Welch JS; Christopher MJ; Heath SE; Baty JD; Schuelke MJ; Payton JE; Spencer DH; Rettig MP; Link DC; Walter MJ; Westervelt P; DiPersio JF; Ley TJ
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845035
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
12. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
13. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
14. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
15. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
[TBL] [Abstract][Full Text] [Related]
16. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Decreased GPX1 Expression in Patients with Acute Myeloid Leukaemia (Non-M3).
Liang X; Yao Y; Li H; Wei J; Wan C; Liu Z
J Coll Physicians Surg Pak; 2021 Aug; 31(8):941-946. PubMed ID: 34320712
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
19. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]